Trademark: SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST
Mark Identification
SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST
Click here to search for trademarks similar to SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST
Proof of use for SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST
We do not have any records of a proof of use for SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST at this moment.
Click here to add a proof of use for SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST
Possible trademark infringements of SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST
Basic Information about SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST
- Serial Number
- 90369415
- Filing Date
- 09 Dec 2020
- Registration Number
- 6485772
- Registration Date
- 14 Sep 2021
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST on the blockchain with WikiTrademarks.io.
- First use of SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST anywhere
- SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST was first used on 09 Nov 2020 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST?
1. Otogenetics Corporation Atlanta GA
2. Otogenetics Corporation Atlanta GA
3. Otogenetics Corporation Atlanta GA
Correspondent
- Daniel E. Sineway
- MORRIS, MANNING & MARTIN, LLP
- 1600 Atlanta Financial Center
- 3343 Peachtree Road, N.E.,
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST